Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,376 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relation of CMV and brain atrophy to trajectories of immunosenescence in diverse populations.
Touil H, Luquez T, Comandante-Lou N, Lee AJ, Fujita M, Habeck C, Kroshilina A, Hegewisch-Solloa E, McInvale J, Zuroff L, Isnard S, Walker E, Zhang L, Routy JP, Zhang Y, Mace EM, Klotz L, Wiendl H, Xia Z, Bar-Or A, Menon V, Stern Y, De Jager PL. Touil H, et al. Among authors: xia z. bioRxiv [Preprint]. 2024 Oct 11:2024.10.07.614568. doi: 10.1101/2024.10.07.614568. bioRxiv. 2024. PMID: 39416188 Free PMC article. Preprint.
Impact of the COVID-19 Pandemic on Personal Networks and Neurological Outcomes of People with Multiple Sclerosis: A Case-Control Cross-sectional and Longitudinal Analysis.
Riley CS, Venkatesh S, Dhand A, Doshi N, Kavak K, Levit EE, Perrone C, Weinstock-Guttman B, Longbrake EE; MSReCOV investigators; De Jager PL, Xia Z. Riley CS, et al. Among authors: xia z. medRxiv [Preprint]. 2022 Nov 29:2022.08.17.22278896. doi: 10.1101/2022.08.17.22278896. medRxiv. 2022. Update in: JMIR Public Health Surveill. 2024 Feb 6;10:e45429. doi: 10.2196/45429. PMID: 36203554 Free PMC article. Updated. Preprint.
A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement.
Straus Farber R, Walker EL, Diallo F, Onomichi K, Riley C, Zhang L, Zhu W, De Jager PL, Xia Z. Straus Farber R, et al. Among authors: xia z. Mult Scler Relat Disord. 2024 Sep;89:105762. doi: 10.1016/j.msard.2024.105762. Epub 2024 Jul 10. Mult Scler Relat Disord. 2024. PMID: 39047340 Free PMC article. Clinical Trial.
A 17q12 allele is associated with altered NK cell subsets and function.
Xia Z, Liu Q, Berger CT, Keenan BT, Kaliszewska A, Cheney PC, Srivastava GP, Castillo IW, De Jager PL, Alter G. Xia Z, et al. J Immunol. 2012 Apr 1;188(7):3315-22. doi: 10.4049/jimmunol.1102775. Epub 2012 Feb 15. J Immunol. 2012. PMID: 22345646 Free PMC article.
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data.
Epstein S, Xia Z, Lee AJ, Dahl M, Edwards K, Levit E, Longbrake EE, Perrone C, Kavak K, Weinstock-Guttman B, Diallo F, Ricci A, Riley CS, De Jager PL, Farber R, Wesley SF; Multiple Sclerosis Resilience to COVID-19 (MSReCOV) Collaborative. Epstein S, et al. Among authors: xia z. Mult Scler Relat Disord. 2022 Jan;57:103433. doi: 10.1016/j.msard.2021.103433. Epub 2021 Dec 2. Mult Scler Relat Disord. 2022. PMID: 34923427 Free PMC article.
6,376 results